Table 1 |. Transgenic models of cancer in the zebrafish.
Cancer | Oncogene | Tumour suppressor |
Use in cancer biology | Refs |
---|---|---|---|---|
Melanoma | mitfa–BRAFV600E | tp53−/− | Genetic and chemical modifier screens |
27, 30,31 |
mitfa:EGFP:NRASQ61K | tp53−/− | |||
kita–Gal4 × uas-HRAS | ||||
Pancreatic | ptf1a–KRASG12V–GFP | Genetic modifier screens | 22,97 | |
ptf1a:Gal4–VP16 × uas–KRASG12V–GFP | ||||
T cell lymphoma or | rag2–myc | Cancer modelling and in vivo imaging | 14,98 | |
leukaemia |
rag2–lox–dsRED2–lox–EGFP– mMyc × hsp70–cre |
Inducible cancer model | 99 | |
rag2–NOTCH1 | NOTCH1 interaction with Bcl‑2 | 100,101 | ||
rag2–myc × rag2–bcl2 | Mechanisms of leukaemia dissemination | 39 | ||
B cell leukaemia |
Xenopus Spp. EF1α or zebrafish B actin– TEL–AML1 (ETV6–RUNX1) |
Initiating events in B cell leukaemia | 34 | |
Numerous | b‑actin–lox–GFP–lox–KRASG12D × hsp70–cre | Inducible cancer model | 102 | |
krt4:Gal4VP16;14 × uas:smoa1– |
Cooperation of hedgehog and AKT pathways | 103 | ||
Rhabdomyosarcoma | rag2–KRASG12D | Identification of tumour-initiating cell populations | 29 | |
Neuroblastoma | dβh:EGFP–MYCN | Cooperation of MYCN and ALK | 23 | |
dβh:EGFP and dβh:ALKF1174L | Cooperation of MYCN and ALK | 23 | ||
AML | pu1–MYST3/NCOA2–EGFP | First model of AML in zebrafish | 104 | |
MPNST | tp53−/− | Conservation of tumour-suppressor pathways in zebrafish |
17 | |
Major tumour type found in p53‑deficient zebrafish | ||||
Lipoma | krt4–myrAKT1 | Platform for the study of drugs to treat lipoma and/or obesity |
105 | |
Ewing’s sarcoma | hsp70 or β-actin–EWSR1–FLI1 | tp53−/− | Conserved function of EWS–FLI1 fusion protein from human to fish |
106 |
Liver |
fabp10:LexPR; LexA:EGFP × cryB:mCherry; LexA:EGFP–krasG12V |
Inducible KRAS‑G12V hepatocellular cancer model | 36 | |
fabp10:TA; TRE:xmrk; krt4:GFP | Inducible EGFR-homologue hepatocellular cancer model |
107 | ||
Pancreatic neuroendocrine |
zmyod–MYCN | Pancreatic neuroendocrine model as a platform for downstream MYCN targets |
108 | |
Myeloproliferative neoplasms |
sp1–NUP98–HOXA9 | NUP98–HOXA9‑induced oncogenesis from defects in haematopoiesis and aberrant DNA damage response |
109 | |
Corticotroph adenoma and neoplasm |
POMC–PTTG | Identification of CDK inhibitors as possible treatment of corticotroph tumours |
110 | |
Testicular germ cell tumour |
fugu flck–SV40 large T | Platform for modifier screens of testicular tumours | 35 |
ALK, anaplastic lymphoma kinase; AML, acute myeloid leukaemia; CDK, cyclin-dependent kinase; EF1α, elongation factor 1α; EGFP, enhanced green fluorescent protein; fabp10, fatty acid-binding protein 10, liver basic; GFP, green fluorescent protein; hsp70, heat shock protein 70; krt4, keratin 4; mitfa, microphthalmia-associated transcription factor a; MPNST, malignant peripheral nerve sheath tumour; myr, myristoylated; POMC, pro-opiomelanocortin; ptf1a, pancreas transcription factor 1 subunit a; PTTG, pituitary tumour-transforming gene; rag2, recombination-activating gene 2; smoa1, activated smoothened mutant; uas, upstream activating sequence.